BeStock  
Markets › Compare › JAZZ vs INSM

JAZZ vs INSM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
JAZZ · Jazz Pharmaceuticals$232.99 ▲ 0.63%
INSM · Insmed$110.96 ▼ 2.79%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5289125162199Oct 2, '25Apr 1, '26Sep 30, '26
  • JAZZ +68.7%
  • INSM -25.3%

Head to head

MetricJAZZINSM
Price$232.99$110.96
Change today▲ 0.63%▼ 2.79%
Market cap$15.12B$24.23B
Return, 3 months-1.9%+3.7%
Return, year to date+37.1%-36.2%
Return, 1 year+70.2%-24.7%
P/E (TTM)15.9-26.9
P/B3.132.0
P/E percentile vs own 5y63rd8th
Dividend yield––
Revenue growth (YoY, latest qtr)+15.5%+296.1%
Net profit growth (YoY)+126.8%+95.9%
Gross margin88.4%83.5%
Operating margin22.1%-71.4%
Net margin20.4%-76.9%
Return on equity22.1%-87.2%
Analyst target vs. price+30.1%+78.6%
Analyst buy share100%100%
RSI (14)3639
30-day volatility27.0%35.4%
Max drawdown, 1 year-11.5%-56.5%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • INSM is the largest of the group by market value.
  • JAZZ has returned the most over the past year.
  • INSM carries the lowest trailing P/E.
  • INSM is growing revenue fastest.
  • JAZZ keeps the most profit per dollar of sales.
  • JAZZ has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top